These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25901857)

  • 1. Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.
    Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Mantovani A; Marchesi F
    Int Rev Immunol; 2015 Mar; 34(2):123-33. PubMed ID: 25901857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.
    Di Caro G; Bergomas F; Grizzi F; Doni A; Bianchi P; Malesci A; Laghi L; Allavena P; Mantovani A; Marchesi F
    Clin Cancer Res; 2014 Apr; 20(8):2147-58. PubMed ID: 24523438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
    Dieu-Nosjean MC; Giraldo NA; Kaplon H; Germain C; Fridman WH; Sautès-Fridman C
    Immunol Rev; 2016 May; 271(1):260-75. PubMed ID: 27088920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.
    Weinstein AM; Storkus WJ
    Adv Cancer Res; 2015; 128():197-233. PubMed ID: 26216634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trafficking of T cells into tumors.
    Slaney CY; Kershaw MH; Darcy PK
    Cancer Res; 2014 Dec; 74(24):7168-74. PubMed ID: 25477332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.
    Galon J; Angell HK; Bedognetti D; Marincola FM
    Immunity; 2013 Jul; 39(1):11-26. PubMed ID: 23890060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.
    Verneau J; Sautés-Fridman C; Sun CM
    Semin Immunol; 2020 Apr; 48():101410. PubMed ID: 33011065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune suppressive mechanisms in the tumor microenvironment.
    Munn DH; Bronte V
    Curr Opin Immunol; 2016 Apr; 39():1-6. PubMed ID: 26609943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity.
    Rausch MP; Sertil AR
    Int Rev Immunol; 2015 Mar; 34(2):104-22. PubMed ID: 25774773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive T-cell therapy: a need for standard immune monitoring.
    Klaver Y; Kunert A; Sleijfer S; Debets R; Lamers CH
    Immunotherapy; 2015; 7(5):513-33. PubMed ID: 26065477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid structures in cancer and beyond.
    Dieu-Nosjean MC; Goc J; Giraldo NA; Sautès-Fridman C; Fridman WH
    Trends Immunol; 2014 Nov; 35(11):571-80. PubMed ID: 25443495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tumor cells and tumor microenvironment on NK-cell function.
    Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
    Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming tumor-mediated immunosuppression.
    Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
    Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.
    Becht E; Giraldo NA; Germain C; de Reyniès A; Laurent-Puig P; Zucman-Rossi J; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
    Adv Immunol; 2016; 130():95-190. PubMed ID: 26923001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.
    Lin L; Hu X; Zhang H; Hu H
    Front Immunol; 2019; 10():1398. PubMed ID: 31281318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells.
    Stone SC; Rossetti RA; Bolpetti A; Boccardo E; Souza PS; Lepique AP
    J Leukoc Biol; 2014 Oct; 96(4):619-31. PubMed ID: 24970861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune microenvironment: a major player in human cancers.
    Fridman WH; Remark R; Goc J; Giraldo NA; Becht E; Hammond SA; Damotte D; Dieu-Nosjean MC; Sautès-Fridman C
    Int Arch Allergy Immunol; 2014; 164(1):13-26. PubMed ID: 24852691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune contexture of primary and metastatic human tumours.
    Giraldo NA; Becht E; Remark R; Damotte D; Sautès-Fridman C; Fridman WH
    Curr Opin Immunol; 2014 Apr; 27():8-15. PubMed ID: 24487185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.